Skip to content
buyWeak

Cameron John Reynolds bought $9,885 of VNRX

President and CEO at VOLITIONRX LTD. 15,000 shares at an average of $0.66, traded Sep 12, 2025, filed Sep 15, 2025.

Conviction score
29
Value
$9,885
15,000 shares
Holdings after
2,624,847
+1% from before
From 52-week low
+57%
low $8.40, close $13.20
From 52-week high
-28%
high $18.40, as of Sep 12, 2025

Score components

  • Role
    CEO
    +25
  • Trade size
    $10k at market
    0
  • Relative to holdings
    Under 1% of holdings (0.6%)
    -5
  • Price context
    28% below the 52-week high
    +4
  • Cluster
    No other insider buying within 14 days
    0
  • Repeat buying
    2 buys in 90 days
    +5
  • Track record
    Too few past buys to judge (0 with prices)
    0

What happened after comparable buys

Same side and tier, against the S&P 500, at 1, 3 and 6 months. Shown to Pro users; the whole table is on the backtest page.

This signal so far: 1m -30.2%, 3m -61.9%, 6m -69.8%.

Price around the trade, and since

From a quarter before the trade to today. The arrow is the trade, the circle the day the filing reached EDGAR, which is the first day anyone outside could act; the dotted line is the S&P 500 rebased to that day's close.

VNRXOct 9, 2026 · close 0.21
Since filing Sep 15, 2025: -98.3%SPY +19.4% · excess -117.7%

Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value; the dashed line is the close on the filing day, the dotted line SPY rebased to it.Charts by TradingView Lightweight Charts™

Rows in this filing

Every transaction in Form 4 0001477932-25-006725, as filed. Open on EDGAR

DateTransactionSharesPriceValueHoldings afterFiled
Sep 12, 2025POpen-market purchase
Common Stock
+15,000$0.66$9,8852,624,847Sep 15, 2025

Related signals

Other insiders at VOLITIONRX LTD and this insider’s other filings.

ScoreCompanyInsiderValueHoldingsFiled
43Moderate
VNRXbuy
VOLITIONRX LTD
Cameron John Reynolds
President and CEO
$7,000
20,000 shares
+1%
63Notable
VNRXbuy 3
VOLITIONRX LTD
Guy Archibald Innes
director
$49k
96,153 shares
+10%
70Notable
VNRXbuy 3
VOLITIONRX LTD
Cameron John Reynolds
President and CEO
$56k
110,000 shares
+5%
48Moderate
VNRXbuy 3
VOLITIONRX LTD
Timothy I Still
director
$25k
48,076 shares
+3%
46Moderate
VNRXbuy 2
VOLITIONRX LTD
Guy Archibald Innes
director
$50k
78,125 shares
+9%
53Moderate
VNRXbuy 2
VOLITIONRX LTD
Cameron John Reynolds
President and CEO
$50k
78,125 shares
+3%
41Moderate
VNRXbuy 2
VOLITIONRX LTD
Cameron John Reynolds
President and CEO
$7,373
12,500 shares
+1%
36Weak
VNRXbuy 2
VOLITIONRX LTD
Guy Archibald Innes
director
$11k
20,000 shares
+2%
44Moderate
VNRXbuy 2
VOLITIONRX LTD
Jacob Vincent Micallef
Chief Scientific Officer
$22k
50,000 shares
+13%
46Moderate
VNRXbuy 2
VOLITIONRX LTD
Cameron John Reynolds
President and CEO
$8,730
20,000 shares
+1%

Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.